Altimmune added to nasdaq biotechnology index

Gaithersburg, md., dec. 19, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will be added to the nasdaq biotechnology index (nasdaq: nbi) effective prior to the market open on monday, december 23, 2024.

ALT Ratings Summary

ALT Quant Ranking